96 related articles for article (PubMed ID: 5764887)
1. [Rubeola vaccination. Serological and clinical studies of the "Cendehill strain" live vaccine].
Zellweger U; Kayser FH; Hitzig WH
Dtsch Med Wochenschr; 1969 Mar; 94(10):461-5. PubMed ID: 5764887
[No Abstract] [Full Text] [Related]
2. [Development of measles vaccination in Austria].
Huber EG; Rannon L
Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
[No Abstract] [Full Text] [Related]
3. Measles (rubeola) in previously immunized children.
Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
[No Abstract] [Full Text] [Related]
4. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
5. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
Böttiger M; Heller L; Kamensky P; Svanberg B
Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
[No Abstract] [Full Text] [Related]
6. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
[No Abstract] [Full Text] [Related]
7. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
Ueda S; Okuno Y; Sakamoto Y
Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
[No Abstract] [Full Text] [Related]
8. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
9. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
[No Abstract] [Full Text] [Related]
10. [Measles vaccination with split vaccines and living vaccines (author's transl)].
Stehr K; Enders-Ruckle G; Spiess H
MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
[TBL] [Abstract][Full Text] [Related]
11. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
Boué A; Celers J
Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
[No Abstract] [Full Text] [Related]
12. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
[No Abstract] [Full Text] [Related]
13. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
14. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
15. [Studies of specific measles prevention].
Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
[No Abstract] [Full Text] [Related]
16. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
17. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
[No Abstract] [Full Text] [Related]
18. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
Willis MF; Warburton MF
Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
[No Abstract] [Full Text] [Related]
19. [Continuous prophylactic vaccination agains measles].
László E; Ferenc F; Eva A; Mária S
Orv Hetil; 1975 May; 116(21):1203-8. PubMed ID: 1128885
[No Abstract] [Full Text] [Related]
20. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
